title: Pioglitazone: Good news for diabetic patients with stroke?
authors.affiliation: Department of Internal Medicine, Hospital Virgen Macarena, University of Seville, Seville, Spain. Electronic address: castillafernandez@hotmail.com.
authors.forename: Luis
authors.initials: L
authors.lastname: Castilla-Guerra
authors.affiliation: Department of Neurology, Hospital de Valme, University of Seville, Seville, Spain.
authors.forename: María Del Carmen
authors.initials: MD
authors.lastname: Fernandez-Moreno
authors.affiliation: Department of Internal Medicine, Hospital Virgen Macarena, Seville, Spain.
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Colmero-Camacho
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D020521:Stroke / Q000150:complications*; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone